Gal-1 in TME has been revealed to support tumor growth by increasing cell adhesion, invasiveness, angiogenesis, and evasion of immune surveillance (Goud et al., 2019; Martinez-Bosch and Navarro, 2020). The gene discussed is LGALS1; the disease is neoplasm.